Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113292495B details a high-yield synthesis of (S)-amino benazepril intermediate using quinine-derived catalysis, offering significant cost and safety advantages for API manufacturing.
Novel hydrogenation route for dibenzyl ethylenediamine acetate. High purity >99%, low cost, scalable pharma intermediate manufacturing.
Patent CN114075201A reveals a novel 2-step route for Sitagliptin Impurity XGT062-05. Achieve high purity via Cope elimination, ensuring reliable API intermediate supply.
Patent CN119654332A reveals a stereoselective route for DNMT1 inhibitor intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Biapenem preparation method improves yield and purity significantly. Suitable for commercial scale-up. Reliable supplier for carbapenem intermediates ensuring supply chain continuity.
Patent CN114450261B reveals safer solvent systems for triketone production. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Advanced purification process for tenofovir prodrug ensuring high purity. Cost-effective supply chain solutions for pharmaceutical intermediates. Reliable manufacturing partner for global pharmaceutical companies seeking scalable synthesis routes.
Novel five-step synthesis for Gefitinib ensures high purity and yield. Optimized for commercial scale-up and supply chain reliability for global buyers.
Patent CN109456156A reveals a high-yield route for BAF312 intermediates. Discover cost-effective manufacturing and reliable supply chain solutions for pharmaceutical production.
Patent CN116178470B reveals a safer one-pot synthesis for ethinylestradiol eliminating acetylene gas. Enhances supply chain reliability and reduces manufacturing complexity.
Patent CN105263913B details a safer thio-1,2,4-triazole synthesis route offering high purity and cost reduction in API manufacturing for global supply chains.
Patent CN119053617A reveals mixed phase synthesis for dual agonists. Enhances purity and yield for reliable pharmaceutical intermediates supplier partnerships globally.
Patent CN110283121A details a green synthesis route improving yield and purity. This offers cost reduction in pharmaceutical manufacturing and supply chain reliability.
Novel chiral resolution method enhances purity and yield for pharmaceutical intermediates. Optimized route ensures cost reduction and supply chain reliability for global buyers.
Novel copper-catalyzed asymmetric synthesis offers high ee values. Enhances supply chain reliability for chiral pharmaceutical intermediates. Cost reduction in API intermediate manufacturing.
Patent CN102939297A details a novel ferroquine synthesis method. This report analyzes the convergent reductive amination route for cost-effective antimalarial API manufacturing.
Patent CN109516950B details a high-yield synthesis of Nicorandil Dimer. This method ensures >99.9% purity, offering reliable supply chain solutions for API manufacturers.
Patent CN105367508B details a high-purity synthesis route for Parecoxib genotoxic impurity enabling cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel quercetin derivative synthesis improves bioavailability. High purity yield offers cost reduction in pharmaceutical intermediates manufacturing.
Patent CN111253406A details a green synthesis route for dihydrobenzo imidazo pyrimidine derivatives using magnetic graphene, offering high purity and recyclable catalysts for reliable pharmaceutical intermediate supply.